These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 17432207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A case of Guillain-Barré syndrome complicated with severe autonomic failure and presented elevated anti-GD1b and anti-GQ1b antibody].
    Inoue K, Kohriyama T, Ikeda J, Maruyama H, Nakamura S.
    Rinsho Shinkeigaku; 2002 Jan; 42(1):13-7. PubMed ID: 12355845
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
    Shahrizaila N, Yuki N.
    Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M, Koga M, Yoshino H, Hamaoka A, Noguchi Y, Hirata K, Yuki N.
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A case with upper limb dominant Guillain-Barré syndrome and serum IgG anti-GT1a antibodies: sparing oropharyngeal palsy].
    Ogawa K, Hoshino H, Takagi M, Mizoi Y, Irie S, Saito T.
    Rinsho Shinkeigaku; 2001 Oct; 41(10):679-82. PubMed ID: 11993188
    [Abstract] [Full Text] [Related]

  • 9. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K.
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [Abstract] [Full Text] [Related]

  • 10. [Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barré syndrome: investigation including serum antiganglioside antibody assay].
    Araki T, Nakata H, Kusunoki S, Arai Y, Katayama Y.
    Rinsho Shinkeigaku; 2000 Oct; 40(10):979-85. PubMed ID: 11296374
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
    van Sorge NM, van der Pol WL, Jansen MD, van den Berg LH.
    Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The immunobiology of Guillain-Barré syndromes.
    Willison HJ.
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [Abstract] [Full Text] [Related]

  • 17. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S.
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F, Gee KE, Vaphiades MS, Biller J, Jay W.
    Semin Ophthalmol; 2006 Jan; 21(4):223-7. PubMed ID: 17182410
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.